Into the depths of ataxia

Journal of Clinical Investigation

Volumn 113, Issue 4, 2004, Pages 505-507

  Orr, Harry T ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; PROTEIN; RILUZOLE;

CEREBELLAR ATAXIA; CEREBELLUM CORTEX; CEREBELLUM NUCLEUS; CLINICAL TRIAL; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; REVIEW; TRANSGENE; ANIMAL; ATAXIA; CYTOLOGY; METABOLISM; NERVE CELL; NOTE; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ATAXIA; CEREBELLAR NUCLEI; HUMANS; NEURONS;

EID: 1642295077     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200421092     Document Type: Review

References (10)

1. Ramón y Cajal, S. 1888. Sobre las fibras nerviosas de la capa molecular del cerebelo. Rev. Trim. Histol. Normal Patol. 1:33-49.
2. Kim, J.J., and Thompson, R.F. 1997. Cerebellar circuits and synaptic mechanisms involved in classical eyeblink conditioning. Trends Neurosci. 20:177-181.
3. Heslow, G., and Ivarsson, M. 1994. Suppression of cerebellar Purkinje cells during conditioned responses in ferrets. Neuroreport. 5:649-652.
4. Shakkottai, V.G., et al. 2004. Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia. J. Clin. Invest. 113:582-590. doi:10.1172/JCI20042021.
5. Aizenman, C.D., and Linden, D.J. 1999. Regulation of the rebound depolarization and spontaneous firing patterns of deep nuclear neurons in slices of rat cerebellum. J. Neurophysiol. 82:1697-1709.
6. Tomita, H., et al. 2003. Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia. Mol. Psychiatry. 8:524-535.
7. Cao, Y.-J., Drexler, J.C., Couey, J.J., and Houamed, K.M. 2002. Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole. Eur. J. Pharmacol. 449:47-54.
8. Lowe, J.S., and Leigh, N. 2002. Disorders of movement and system degenerations. In Greenfield's neuropathology. Volume 2. 7th edition. D.I. Graham and P.L. Lantos, editors. Arnold Publishing. New York, New York, USA/London, United Kingdom. 325-430.
9. Festoff, B.W., Suo, Z., and Citron, B.A. 2003. Prospects for pharmacotherapy of amyotrophic lateral sclerosis: old strategies and new paradigms for the third millennium. CNS Drugs. 17:699-717.
10. Raman, I.M., Gustafson, A.E., and Padgett, D. 2000. Ionic currents and spontaneous firing in neurons isolated from the cerebellar nuclei. J. Neurosci. 20:9004-9016.